Black Rock Inc. Benitec Biopharma Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.74 - $2.29 $14,469 - $44,778	-19,554 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.96 - $2.96 $1,852 - $2,797	-945 Reduced 4.61%	19,554 $46,000
Q4 2021 Feb 10, 2022	BUY	$2.62 - $3.77 $1,375 - $1,979	525 Added 2.63%	20,499 $53,000
Q3 2021 Nov 09, 2021	SELL	$3.49 - $4.26 $13,687 - $16,707	-3,922 Reduced 16.41%	19,974 $71,000
Q2 2021 Aug 11, 2021	BUY	$3.94 - $5.81 $94,150 - $138,835	23,896 New	23,896 $101,000

797K

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $261M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.